This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.25 mg softgel capsules of the drug Talzenna, with a ceiling value of $11,135.25 and a completion date of June 11, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $10,784.34 with a completion date of February 4, 2025. It is for the supply of Talzenna 0.5 mg Capsule 30s, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,246.91, is a delivery order for the supply of a specific pharmaceutical product, Talzenna 0.5 mg softgel 30s. The contract is a firm fixed-price, non-set-aside arrangement with a completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,784.34 firm fixed-price delivery order is for the supply of TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,135.25 firm-fixed-price contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALZENNA 0.5 MG SOFTGEL 30S, a pharmaceutical product, with a ceiling value of $11,135.25 and a completion date of June 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $21,568.70 and a period of performance through March 7, 2025. It is a firm fixed-price contract and does not have any set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,424.08 firm-fixed-price delivery order is for the supply of 4565190685 - TALZENNA 1 MG CAPSULE 30S, a prescription medication. This award does not utilize a set-aside and has an ultimate completion date of August 8, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This federal contract award, valued at $10,784.34, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the medical product TALZENNA 0.5 MG CAPSULE 30S, with a performance period ending on March 27, 2025. The contract is a firm fixed-price arrangement, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, valued at $10,784.34, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award covers the delivery of 4566702246 TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 6, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company...